The Journal of Immunology, Vol 155, Issue 3 1326-1333, Copyright © 1995 by American Association of Immunologists

ARTICLES

Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1

K Ikemoto, RB Pollard, T Fukumoto, M Morimatsu and F Suzuki
Department of Neurology, Yamaguchi University School of Medicine, Japan.

The effect of murine rIL-4 on the development of herpesvirus encephalitis (HSE) in mice infected intranasally with herpes simplex virus type 1 (HSV-1) was investigated. The mortality rates of mice infected with a 0.5 LD50 dose of HSV-1 were greatly increased after the administration of rIL-4 at doses ranging from 0.01 to 1.0 U/mouse 2 h before and 2, 4 and 6 days after the infection. In contrast, survival rates of mice exposed to a 5 LD50 dose of HSV-1 were clearly increased when these mice were treated with anti-IL-4 mAb. Cervical lymph node (CLN) cells and cerebrospinal fluid (CSF) cells from mice with HSE (HSE mice) produced IL-4 in their culture fluids when they were stimulated in vitro with HSV-1 Ag. Increased amounts of HSV-1 infection in mice resulted in the increased production of IL-4 in the culture fluids of local lymphocytes. However, significant amounts of IL-4 were not produced in serum specimens or in culture fluids of spleen cells from HSE mice. IL-4 production in culture fluids of CLN and CSF cells from HSE mice was clearly reduced after treatment of HSE mice with anti-IL-4 mAb. Furthermore, IL-4 production by CLN and CSF cells was greatly enhanced when the cells were prepared from HSE mice previously treated with rIL-4. The IL-4 was mainly produced from CD4+ T cells. These results demonstrate that small amounts of exogenous IL-4 increase the severity of HSE in HSV-1-infected mice through the increased production of IL-4 from local CD4+ T cells.

This article has been cited by other articles:

				P. A. Sheridan and M. A. Beck The Immune Response to Herpes Simplex Virus Encephalitis in Mice Is Modulated by Dietary Vitamin E J. Nutr., January 1, 2008; 138(1): 130 - 137. [Abstract] [Full Text] [PDF]

				C. M. Richards, R. Case, T. R. Hirst, T. J. Hill, and N. A. Williams Protection against Recurrent Ocular Herpes Simplex Virus Type 1 Disease after Therapeutic Vaccination of Latently Infected Mice J. Virol., June 15, 2003; 77(12): 6692 - 6699. [Abstract] [Full Text] [PDF]

				H. Nakajima, M. Kobayashi, R. B. Pollard, and F. Suzuki Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses J. Leukoc. Biol., September 1, 2001; 70(3): 374 - 380. [Abstract] [Full Text] [PDF]

				K. Furukawa, H. Sasaki, R. B. Pollard, and F. Suzuki Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice against encephalitis caused by Cryptococcus neoformans J. Antimicrob. Chemother., September 1, 2000; 46(3): 443 - 450. [Abstract] [Full Text] [PDF]

				M. Kaji, M. Kobayashi, R. B Pollard, and F. Suzuki Influence of type 2 T cell responses on the severity of encephalitis associated with influenza virus infection J. Leukoc. Biol., August 1, 2000; 68(2): 180 - 186. [Abstract] [Full Text]

				H. Kobayashi, M. Kobayashi, T. Utsunomiya, D. N. Herndon, R. B. Pollard, and F. Suzuki Therapeutic Protective Effects of IL-12 Combined with Soluble IL-4 Receptor Against Established Infections of Herpes Simplex Virus Type 1 in Thermally Injured Mice J. Immunol., June 15, 1999; 162(12): 7148 - 7154. [Abstract] [Full Text] [PDF]

				K. Goldsmith, W. Chen, D. C. Johnson, and R. L. Hendricks Infected Cell Protein (ICP)47 Enhances Herpes Simplex Virus Neurovirulence by Blocking the CD8+ T Cell Response J. Exp. Med., February 2, 1998; 187(3): 341 - 348. [Abstract] [Full Text] [PDF]